Non-Dopaminergic Therapies

Currently all aspects of Parkinson’s disease (PD) treatment are less than ideal and would benefit from new interventions. We focus on problems associated with brain neurotransmitters amenable to more specific subreceptor and temporal manipulation. In addition, we consider potentially treatable CNS n...

Descripción completa

Detalles Bibliográficos
Autores principales: Nutt, John G., Bohnen, Nicolaas I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311374/
https://www.ncbi.nlm.nih.gov/pubmed/30584157
http://dx.doi.org/10.3233/JPD-181472
_version_ 1783383605165162496
author Nutt, John G.
Bohnen, Nicolaas I.
author_facet Nutt, John G.
Bohnen, Nicolaas I.
author_sort Nutt, John G.
collection PubMed
description Currently all aspects of Parkinson’s disease (PD) treatment are less than ideal and would benefit from new interventions. We focus on problems associated with brain neurotransmitters amenable to more specific subreceptor and temporal manipulation. In addition, we consider potentially treatable CNS non-PD co-pathologies or co-morbidities that may exacerbate progression of various aspects of PD.
format Online
Article
Text
id pubmed-6311374
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher IOS Press
record_format MEDLINE/PubMed
spelling pubmed-63113742019-01-02 Non-Dopaminergic Therapies Nutt, John G. Bohnen, Nicolaas I. J Parkinsons Dis Review Currently all aspects of Parkinson’s disease (PD) treatment are less than ideal and would benefit from new interventions. We focus on problems associated with brain neurotransmitters amenable to more specific subreceptor and temporal manipulation. In addition, we consider potentially treatable CNS non-PD co-pathologies or co-morbidities that may exacerbate progression of various aspects of PD. IOS Press 2018-12-18 /pmc/articles/PMC6311374/ /pubmed/30584157 http://dx.doi.org/10.3233/JPD-181472 Text en © 2018 – IOS Press and the authors. All rights reserved https://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) License (https://creativecommons.org/licenses/by-nc/4.0/) , which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Nutt, John G.
Bohnen, Nicolaas I.
Non-Dopaminergic Therapies
title Non-Dopaminergic Therapies
title_full Non-Dopaminergic Therapies
title_fullStr Non-Dopaminergic Therapies
title_full_unstemmed Non-Dopaminergic Therapies
title_short Non-Dopaminergic Therapies
title_sort non-dopaminergic therapies
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311374/
https://www.ncbi.nlm.nih.gov/pubmed/30584157
http://dx.doi.org/10.3233/JPD-181472
work_keys_str_mv AT nuttjohng nondopaminergictherapies
AT bohnennicolaasi nondopaminergictherapies

Ejemplares similares